ALBT Avalon GloboCare Corp
3,112
$0.3079
$0.0293
(10.52%)
| Watchers | 3,112 |
| 52-Wk Low | $0.24 |
| 52-Wk High | $2.42 |
| Market Cap | $3.42M |
| Volume | 24,453.00 |
| 52-Wk High | $2.42 |
| 52-Wk Low | $0.24 |
Analyzing Avalon GloboCare (NASDAQ:ALBT) & Vaxcyte (NASDAQ:PCVX)Ticker Report • about 2 months ago
Avalon GloboCare (NASDAQ:ALBT - Get Free Report) and Vaxcyte (NASDAQ:PCVX - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based...
Share to Feed
Avalon GloboCare Corp. (NASDAQ:ALBT Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
FREEHOLD, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ( Avalon or the Company ) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision...
Avalon GloboCare Corp. (NASDAQ:ALBT Get Free Report) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 54,400 shares, an...
Avalon GloboCare Corp. (NASDAQ:ALBT Get Free Report) saw a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 56,900...